We are live on
!
Find out more
DCM
Driehaus Capital Management Portfolio holdings
AUM
$13.6B
1-Year Est. Return
173.98%
This Fund
S&P 500
This Quarter
Est. Return
-10.34%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$6.17B
AUM Growth
-$1.97B
(-24%)
Cap. Flow
-$820M
Cap. Flow
% of AUM
-13.27%
Top 10 Holdings %
Top 10 Hldgs %
17.81%
Holding
470
New
92
Increased
125
Reduced
120
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTI Consulting
FCN
|
+$54.3M |
| 2 |
Xenon Pharmaceuticals
XENE
|
+$33M |
| 3 |
Flywire
FLYW
|
+$32.6M |
| 4 |
America Movil
AMX
|
+$31M |
| 5 |
FIVE9
FIVN
|
+$29.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$85.8M |
| 2 |
United Parks & Resorts
PRKS
|
+$64.2M |
| 3 |
Vale
VALE
|
+$56.2M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$46M |
| 5 |
Axcelis
ACLS
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.12% |
| 2 | Technology | 17.89% |
| 3 | Industrials | 14.18% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Financials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
AbbVie
ABBV
$455B
| $281K | ﹤0.01% |
+1,836
| New | +$281K |
|
327
Berkshire Hathaway Class B
BRK.B
$1.1T
| $276K | ﹤0.01% |
+1,011
| New | +$317K |
|
328
CVS Health
CVS
$134B
| $274K | ﹤0.01% |
2,962
-13
| -0.4% | -$1.27K |
|
329
Thermo Fisher Scientific
TMO
$214B
| $274K | ﹤0.01% |
504
+20
| +4% | +$11K |
|
330
Public Storage
PSA
$59.3B
| $273K | ﹤0.01% |
873
-82
| -9% | -$28.4K |
|
331
Alphabet (Google) Class A
GOOGL
$4.08T
| $272K | ﹤0.01% |
2,500
-40
| -2% | -$4.71K |
|
332
Broadcom
AVGO
$1.85T
| $267K | ﹤0.01% |
5,490
+690
| +14% | +$38.7K |
|
333
Prologis
PLD
$136B
| $263K | ﹤0.01% |
+2,238
| New | +$309K |
|
334
Arthur J. Gallagher & Co
AJG
$65.9B
| $259K | ﹤0.01% |
+1,587
| New | +$263K |
|
|
DFS
335
DELISTED
Discover Financial Services
DFS
| $258K | ﹤0.01% |
+2,725
| New | +$292K |
|
|
NOTV
336
DELISTED
Inotiv
NOTV
| $256K | ﹤0.01% |
26,690
-398,795
| -94% | -$6.68M |
|
337
Danaher
DHR
$138B
| $246K | ﹤0.01% |
1,096
+30
| +3% | +$6.91K |
|
|
IPG
338
DELISTED
Interpublic Group of Companies
IPG
| $238K | ﹤0.01% |
+8,646
| New | +$274K |
|
339
Weyerhaeuser
WY
$16.9B
| $238K | ﹤0.01% |
7,187
+1,862
| +35% | +$71K |
|
340
Meta Platforms (Facebook)
META
$1.37T
| $231K | ﹤0.01% |
1,431
-39
| -3% | -$7.52K |
|
341
General Mills
GIS
$19.4B
| $228K | ﹤0.01% |
+3,027
| New | +$212K |
|
|
LSI
342
DELISTED
Life Storage, Inc.
LSI
| $224K | ﹤0.01% |
2,003
+32
| +2% | +$3.95K |
|
343
Genuine Parts
GPC
$17.2B
| $216K | ﹤0.01% |
+1,626
| New | +$216K |
|
344
Merck
MRK
$321B
| $214K | ﹤0.01% |
+2,349
| New | +$208K |
|
345
Apollo Global Management
APO
$69.3B
| $208K | ﹤0.01% |
+4,285
| New | +$233K |
|
346
Elevance Health
ELV
$81.6B
| $205K | ﹤0.01% |
+424
| New | +$210K |
|
347
Cisco
CSCO
$448B
| $202K | ﹤0.01% |
4,728
+309
| +7% | +$14.8K |
|
348
Automatic Data Processing
ADP
$105B
| $200K | ﹤0.01% |
954
-308
| -24% | -$67.5K |
|
|
AUY
349
DELISTED
Yamana Gold, Inc.
AUY
| $168K | ﹤0.01% |
36,225
-3,910,172
| -99% | -$21.2M |
|
350
CALL
Kohl's
KSS
$2.21B
| $158K | ﹤0.01% |
+750,000
| New | +$36.8M |
|
Similar funds
CC
PMAM
SA
PSCM
WHG
AA
WA
SAM
Driehaus Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Driehaus Capital Management held 470 positions worth $6.17B, down 24% from $8.14B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Driehaus Capital Management withdrew a net $820M in Q2 2022, closing 118 positions and reducing 120 holdings. Its most notable exit was Infosys, an estimated $85.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Driehaus Capital Management opened a new position in FTI Consulting worth $59.5M.
- Driehaus Capital Management's largest Q2 2022 buy was FTI Consulting: 329,108 shares worth $59.5M.
- Driehaus Capital Management added most to Xenon Pharmaceuticals in Q2 2022, an estimated $33M increase.
- Driehaus Capital Management's biggest Q2 2022 reduction was Axcelis, cutting an estimated $45.1M.
- Driehaus Capital Management fully exited Infosys in Q2 2022, selling an estimated $85.8M.
- Driehaus Capital Management's ten largest holdings make up 18% of its $6.17B portfolio in Q2 2022.
- Driehaus Capital Management opened 92 new positions and closed 118 in Q2 2022.
- Driehaus Capital Management's portfolio value fell 24% quarter-over-quarter to $6.17B.
Based on Driehaus Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.